PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PFE vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PFE and XLV is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

PFE vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pfizer Inc. (PFE) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%AugustSeptemberOctoberNovemberDecember2025
-8.50%
-4.96%
PFE
XLV

Key characteristics

Sharpe Ratio

PFE:

-0.04

XLV:

0.20

Sortino Ratio

PFE:

0.11

XLV:

0.34

Omega Ratio

PFE:

1.01

XLV:

1.04

Calmar Ratio

PFE:

-0.02

XLV:

0.17

Martin Ratio

PFE:

-0.10

XLV:

0.46

Ulcer Index

PFE:

8.69%

XLV:

4.64%

Daily Std Dev

PFE:

22.94%

XLV:

10.97%

Max Drawdown

PFE:

-54.82%

XLV:

-39.17%

Current Drawdown

PFE:

-50.82%

XLV:

-10.11%

Returns By Period

In the year-to-date period, PFE achieves a -0.87% return, which is significantly lower than XLV's 1.90% return. Over the past 10 years, PFE has underperformed XLV with an annualized return of 2.42%, while XLV has yielded a comparatively higher 8.84% annualized return.


PFE

YTD

-0.87%

1M

-0.23%

6M

-8.50%

1Y

-1.32%

5Y*

-3.08%

10Y*

2.42%

XLV

YTD

1.90%

1M

2.04%

6M

-4.96%

1Y

2.11%

5Y*

7.74%

10Y*

8.84%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PFE vs. XLV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PFE
The Risk-Adjusted Performance Rank of PFE is 4040
Overall Rank
The Sharpe Ratio Rank of PFE is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3535
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3434
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4444
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4343
Martin Ratio Rank

XLV
The Risk-Adjusted Performance Rank of XLV is 1010
Overall Rank
The Sharpe Ratio Rank of XLV is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of XLV is 99
Sortino Ratio Rank
The Omega Ratio Rank of XLV is 1010
Omega Ratio Rank
The Calmar Ratio Rank of XLV is 1212
Calmar Ratio Rank
The Martin Ratio Rank of XLV is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PFE vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PFE, currently valued at -0.04, compared to the broader market-2.000.002.004.00-0.040.20
The chart of Sortino ratio for PFE, currently valued at 0.11, compared to the broader market-4.00-2.000.002.004.006.000.110.34
The chart of Omega ratio for PFE, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.04
The chart of Calmar ratio for PFE, currently valued at -0.02, compared to the broader market0.002.004.006.00-0.020.17
The chart of Martin ratio for PFE, currently valued at -0.10, compared to the broader market-10.000.0010.0020.0030.00-0.100.46
PFE
XLV

The current PFE Sharpe Ratio is -0.04, which is lower than the XLV Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of PFE and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
-0.04
0.20
PFE
XLV

Dividends

PFE vs. XLV - Dividend Comparison

PFE's dividend yield for the trailing twelve months is around 6.39%, more than XLV's 1.64% yield.


TTM20242023202220212020201920182017201620152014
PFE
Pfizer Inc.
6.39%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%
XLV
Health Care Select Sector SPDR Fund
1.64%1.67%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%

Drawdowns

PFE vs. XLV - Drawdown Comparison

The maximum PFE drawdown since its inception was -54.82%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for PFE and XLV. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-50.82%
-10.11%
PFE
XLV

Volatility

PFE vs. XLV - Volatility Comparison

Pfizer Inc. (PFE) has a higher volatility of 6.51% compared to Health Care Select Sector SPDR Fund (XLV) at 3.59%. This indicates that PFE's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
6.51%
3.59%
PFE
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab